Published in
Taylor and Francis Group, Human Vaccines and Immunotherapeutics, 1(19), 2023
DOI: 10.1080/21645515.2023.2193074
Links
Tools
Immunogenicity and safety of single booster dose of KD-414 inactivated COVID-19 vaccine in adults: An open-label, single-center, non-randomized, controlled study in Japan
Journal article published in 2023 by
Junko Terada-Hirashima 
,
Yuki Takamatsu,
Yosuke Shimizu,
Yukari Uemura,
Junko S. Takeuchi,
Noriko Tomita,
Kouki Matsuda,
Kenji Maeda,
Shohei Yamamoto,
Ami Fukunaga,
Norio Ohmagari,
Ayako Mikami,
Kengo Sonoda,
Mugen Ujiie,
Hiroaki Mitsuya
and other authors.
,
Yuki Takamatsu,
Yosuke Shimizu,
Yukari Uemura,
Junko S. Takeuchi,
Noriko Tomita,
Kouki Matsuda,
Kenji Maeda,
Shohei Yamamoto,
Ami Fukunaga,
Norio Ohmagari,
Ayako Mikami,
Kengo Sonoda,
Mugen Ujiie,
Hiroaki Mitsuya
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 